Breaking News Instant updates and real-time market news.

SHBI

Shore Bancshares

$16.21 /

+0.67 (+4.31%)

, SVBI

Severn Bancorp, Inc.

$8.35 /

+0.13 (+1.58%)

17:01
03/03/21
03/03
17:01
03/03/21
17:01

Shore Bancshares, Severn to merge in roughly $146M deal

Shore Bancshares (SHBI) and Severn Bancorp (SVBI) announced they have entered into a definitive agreement under which Severn will merge with and into Shore in a stock and cash transaction valued at approximately $146M, or $11.30 per share of Severn common stock, based on a closing price for Shore's common stock of $15.64 as of March 2, 2021 and $1.59 per share in cash. Shore expects the transaction to be over 30% accretive to EPS in 2022, based on anticipated cost savings of approximately 35%. Under the terms of the definitive agreement, which was unanimously approved by the Board of Directors of both companies, holders of Severn common stock will have the right to receive 0.6207 shares of Shore common stock and $1.59 in cash for each share of Severn common stock they own. Since the exchange ratio will be fixed at 0.6207, the common stock value of the consideration will float with Shore's stock price. The cash portion of the consideration will be fixed at $1.59 per share. The transaction is expected to close in the third quarter of 2021, subject to satisfaction of customary closing conditions, including regulatory approvals and shareholder approval from Shore and Severn shareholders. Severn directors, executive officers and certain shareholders have entered into agreements with Shore pursuant to which they have committed to vote their shares of Severn common stock in favor of the merger of Severn with and into Shore. Shore directors and executive officers have entered into agreements with Severn pursuant to which they have committed to vote their shares of Shore common stock in favor of the issuance of shares of Shore to Severn shareholders in the merger.

SHBI

Shore Bancshares

$16.21 /

+0.67 (+4.31%)

SVBI

Severn Bancorp, Inc.

$8.35 /

+0.13 (+1.58%)

TODAY'S FREE FLY STORIES

General news
Oil Action: WTI crude » 08:35
04/12/21
04/12
08:35
04/12/21
08:35
$ECON

Economic Data

/

+

Oil Action: WTI crude is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
    Hot Stocks
    Artelo Biosciences doses first patient in CAReS study with ART27.13 » 08:34
    04/12/21
    04/12
    08:34
    04/12/21
    08:34
    ARTL

    Artelo Biosciences

    $1.53 /

    -0.055 (-3.47%)

    Artelo Biosciences…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    ARTL Artelo Biosciences
    $1.53 /

    -0.055 (-3.47%)

    ARTL Artelo Biosciences
    $1.53 /

    -0.055 (-3.47%)

    02/12/21 Ladenburg
    Artelo Biosciences initiated with a Buy at Ladenburg
    01/07/21 Maxim
    Artelo Biosciences upgraded to Buy from Hold at Maxim
    01/07/21 Maxim
    Artelo Biosciences upgraded to Buy from Hold at Maxim
    05/13/20 Maxim
    Artelo Biosciences downgraded to Hold from Buy at Maxim
    ARTL Artelo Biosciences
    $1.53 /

    -0.055 (-3.47%)

    • 09
      Oct
    Recommendations
    Chicken Soup for the Soul price target raised to $48 from $35 at Craig-Hallum » 08:34
    04/12/21
    04/12
    08:34
    04/12/21
    08:34
    CSSE

    Chicken Soup for the Soul

    $32.50 /

    +4.54 (+16.24%)

    Craig-Hallum analyst…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    CSSE Chicken Soup for the Soul
    $32.50 /

    +4.54 (+16.24%)

    CSSE Chicken Soup for the Soul
    $32.50 /

    +4.54 (+16.24%)

    08:23 Today Northland
    Chicken Soup for the Soul price target raised to $40 from $30 at Northland
    04/09/21 Alliance Global Partners
    Alliance Global raises Chicken Soup for the Soul price target to $48 after deal
    04/01/21 DA Davidson
    Chicken Soup for the Soul price target raised to $34 from $28 at DA Davidson
    04/01/21 Craig-Hallum
    Chicken Soup for the Soul price target raised to $35 from $30 at Craig-Hallum
    Hot Stocks
    Infinity Energy completes purchase of production, acresin Central Kansas Uplift » 08:33
    04/12/21
    04/12
    08:33
    04/12/21
    08:33
    IFNY

    Infinity Energy Resources

    /

    +

    Infinity Energy Resources…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    Recommendations
    B. Riley calls Agenus the next Seagen, reiterates $8 target » 08:33
    04/12/21
    04/12
    08:33
    04/12/21
    08:33
    AGEN

    Agenus

    $2.78 /

    -0.01 (-0.36%)

    , MRK

    Merck

    $76.33 /

    +0.855 (+1.13%)

    , BMY

    Bristol-Myers

    $62.61 /

    +0.695 (+1.12%)

    , AZN

    AstraZeneca

    $49.95 /

    +0.465 (+0.94%)

    , RHHBY

    Roche

    $41.93 /

    +0.53 (+1.28%)

    , SGEN

    Seagen

    $142.81 /

    -1.68 (-1.16%)

    B. Riley analyst Mayank…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    AGEN Agenus
    $2.78 /

    -0.01 (-0.36%)

    MRK Merck
    $76.33 /

    +0.855 (+1.13%)

    BMY Bristol-Myers
    $62.61 /

    +0.695 (+1.12%)

    AZN AstraZeneca
    $49.95 /

    +0.465 (+0.94%)

    RHHBY Roche
    $41.93 /

    +0.53 (+1.28%)

    SGEN Seagen
    $142.81 /

    -1.68 (-1.16%)

    AGEN Agenus
    $2.78 /

    -0.01 (-0.36%)

    09/22/20 B. Riley FBR
    B. Riley FBR calls Agenus 'hidden gem' amidst ESMO data releases
    09/18/20 Jefferies
    Agenus price target raised to $8 from $5 at Jefferies
    MRK Merck
    $76.33 /

    +0.855 (+1.13%)

    04/08/21 Alliance Global Partners
    Alliance Global Partners sees Fast Track for Immutep efti as meaningful positive
    04/08/21 H.C. Wainwright
    Alkermes collaboration not as big as investors wanted, says H.C. Wainwright
    04/07/21 Mizuho
    Mizuho sees Alkermes, Merck collaboration as important next step for nemvaleukin
    04/06/21 RBC Capital
    Merck transferred with a Sector Perform at RBC Capital
    BMY Bristol-Myers
    $62.61 /

    +0.695 (+1.12%)

    03/08/21 BofA
    Gartner added to US 1 List, Bristol-Myers removed at BofA
    02/12/21 Morgan Stanley
    Amgen court decision may have readthrough for Gilead, says Morgan Stanley
    02/02/21 BTIG
    Prothena upgraded to Buy at BTIG on birtamimab 'revival'
    01/20/21 William Blair
    Exelixis selloff on competitive concerns an 'overreaction,' says William Blair
    AZN AstraZeneca
    $49.95 /

    +0.465 (+0.94%)

    07:18 Today Argus
    AstraZeneca downgraded to Hold from Buy at Argus
    07:09 Today Argus
    AstraZeneca downgraded to Hold from Buy at Argus
    04/07/21 Citi
    FibroGen update creates only 'bad optic' for AstraZeneca, says Citi
    03/26/21 Piper Sandler
    AstraZeneca plan 'opens the door' for Altimmune interest, says Piper Sandler
    RHHBY Roche
    $41.93 /

    +0.53 (+1.28%)

    03/29/21 RBC Capital
    PTC Therapeutics upgraded to Sector Perform at RBC Capital on valuation
    03/25/21 Wedbush
    iTeos Therapeutics price target raised to $52 from $46 at Wedbush
    03/23/21 Truist
    Truist sees mixed readthroughs to Wave's toplines from competitor HD setback
    03/23/21 BMO Capital
    Ionis Pharmaceuticals price target lowered to $76 from $90 at BMO Capital
    SGEN Seagen
    $142.81 /

    -1.68 (-1.16%)

    03/30/21 Credit Suisse
    Seagen initiated with a Neutral at Credit Suisse
    03/30/21 Credit Suisse
    Seagen initiated with a Neutral at Credit Suisse
    02/16/21 RBC Capital
    Seagen price target lowered to $169 from $186 at RBC Capital
    02/12/21 Barclays
    Seagen price target lowered to $168 from $177 at Barclays
    AGEN Agenus
    $2.78 /

    -0.01 (-0.36%)

    MRK Merck
    $76.33 /

    +0.855 (+1.13%)

    BMY Bristol-Myers
    $62.61 /

    +0.695 (+1.12%)

    AZN AstraZeneca
    $49.95 /

    +0.465 (+0.94%)

    RHHBY Roche
    $41.93 /

    +0.53 (+1.28%)

    SGEN Seagen
    $142.81 /

    -1.68 (-1.16%)

    MRK Merck
    $76.33 /

    +0.855 (+1.13%)

    BMY Bristol-Myers
    $62.61 /

    +0.695 (+1.12%)

    AZN AstraZeneca
    $49.95 /

    +0.465 (+0.94%)

    RHHBY Roche
    $41.93 /

    +0.53 (+1.28%)

    MRK Merck
    $76.33 /

    +0.855 (+1.13%)

    BMY Bristol-Myers
    $62.61 /

    +0.695 (+1.12%)

    AZN AstraZeneca
    $49.95 /

    +0.465 (+0.94%)

    RHHBY Roche
    $41.93 /

    +0.53 (+1.28%)

    SGEN Seagen
    $142.81 /

    -1.68 (-1.16%)

    MRK Merck
    $76.33 /

    +0.855 (+1.13%)

    BMY Bristol-Myers
    $62.61 /

    +0.695 (+1.12%)

    AZN AstraZeneca
    $49.95 /

    +0.465 (+0.94%)

    Hot Stocks
    Homology Medicines announces promotion of Tim Kelly to COO » 08:32
    04/12/21
    04/12
    08:32
    04/12/21
    08:32
    FIXX

    Homology Medicines

    $7.30 /

    -0.17 (-2.28%)

    Homology Medicines…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    FIXX Homology Medicines
    $7.30 /

    -0.17 (-2.28%)

    FIXX Homology Medicines
    $7.30 /

    -0.17 (-2.28%)

    03/01/21 Stifel
    Homology Medicines initiated with a Hold at Stifel
    03/01/21 Oppenheimer
    Homology Medicines loses potential source of upside, says Oppenheimer
    12/14/20 H.C. Wainwright
    Homology Medicines transferred with Buy, $30 target at H.C. Wainwright
    11/08/20 Oppenheimer
    Homology Medicines selloff unjustified in wake of clinical PoC, says Oppenheimer
    FIXX Homology Medicines
    $7.30 /

    -0.17 (-2.28%)

    • 07
      Apr
    FIXX Homology Medicines
    $7.30 /

    -0.17 (-2.28%)

    Hot Stocks
    Homology Medicines announces promotion of Tim Kelly to COO » 08:32
    04/12/21
    04/12
    08:32
    04/12/21
    08:32
    FIXX

    Homology Medicines

    $7.30 /

    -0.17 (-2.28%)

    Homology Medicines…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    FIXX Homology Medicines
    $7.30 /

    -0.17 (-2.28%)

    FIXX Homology Medicines
    $7.30 /

    -0.17 (-2.28%)

    03/01/21 Stifel
    Homology Medicines initiated with a Hold at Stifel
    03/01/21 Oppenheimer
    Homology Medicines loses potential source of upside, says Oppenheimer
    12/14/20 H.C. Wainwright
    Homology Medicines transferred with Buy, $30 target at H.C. Wainwright
    11/08/20 Oppenheimer
    Homology Medicines selloff unjustified in wake of clinical PoC, says Oppenheimer
    FIXX Homology Medicines
    $7.30 /

    -0.17 (-2.28%)

    • 07
      Apr
    FIXX Homology Medicines
    $7.30 /

    -0.17 (-2.28%)

    Hot Stocks
    Microsoft to acquire Nuance for $56.00 per share in cash  08:32
    04/12/21
    04/12
    08:32
    04/12/21
    08:32
    MSFT

    Microsoft

    $255.73 /

    +2.37 (+0.94%)

    , NUAN

    Nuance

    $45.59 /

    +0.38 (+0.84%)

     
    ShowHide Related Items >><<
    MSFT Microsoft
    $255.73 /

    +2.37 (+0.94%)

    NUAN Nuance
    $45.59 /

    +0.38 (+0.84%)

    MSFT Microsoft
    $255.73 /

    +2.37 (+0.94%)

    08:30 Today Stifel
    Microsoft a 'logical buyer' of Nuance, says Stifel
    07:36 Today B. Riley
    Nuance possible takeout positive for peer LivePerson, says B. Riley
    07:29 Today Wedbush
    Nuance deal would be 'trophy' for Microsoft, says Wedbush
    07:11 Today BMO Capital
    Microsoft price target raised to $280 from $270 at BMO Capital
    NUAN Nuance
    $45.59 /

    +0.38 (+0.84%)

    08:30 Today Stifel
    Microsoft a 'logical buyer' of Nuance, says Stifel
    07:36 Today B. Riley
    Nuance possible takeout positive for peer LivePerson, says B. Riley
    07:29 Today Wedbush
    Nuance deal would be 'trophy' for Microsoft, says Wedbush
    03/10/21 Wedbush
    Nuance added to Best Ideas List at Wedbush
    MSFT Microsoft
    $255.73 /

    +2.37 (+0.94%)

    NUAN Nuance
    $45.59 /

    +0.38 (+0.84%)

    MSFT Microsoft
    $255.73 /

    +2.37 (+0.94%)

    NUAN Nuance
    $45.59 /

    +0.38 (+0.84%)

    MSFT Microsoft
    $255.73 /

    +2.37 (+0.94%)

    NUAN Nuance
    $45.59 /

    +0.38 (+0.84%)

    MSFT Microsoft
    $255.73 /

    +2.37 (+0.94%)

    NUAN Nuance
    $45.59 /

    +0.38 (+0.84%)

    Recommendations
    Microsoft a 'logical buyer' of Nuance, says Stifel » 08:30
    04/12/21
    04/12
    08:30
    04/12/21
    08:30
    NUAN

    Nuance

    $45.59 /

    +0.38 (+0.84%)

    , MSFT

    Microsoft

    $255.73 /

    +2.37 (+0.94%)

    After Bloomberg reported…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    NUAN Nuance
    $45.59 /

    +0.38 (+0.84%)

    MSFT Microsoft
    $255.73 /

    +2.37 (+0.94%)

    NUAN Nuance
    $45.59 /

    +0.38 (+0.84%)

    07:36 Today B. Riley
    Nuance possible takeout positive for peer LivePerson, says B. Riley
    07:29 Today Wedbush
    Nuance deal would be 'trophy' for Microsoft, says Wedbush
    03/10/21 Wedbush
    Nuance added to Best Ideas List at Wedbush
    03/08/21 Morgan Stanley
    Software industry rating raised to Attractive from In-Line at Morgan Stanley
    MSFT Microsoft
    $255.73 /

    +2.37 (+0.94%)

    07:36 Today B. Riley
    Nuance possible takeout positive for peer LivePerson, says B. Riley
    07:29 Today Wedbush
    Nuance deal would be 'trophy' for Microsoft, says Wedbush
    07:11 Today BMO Capital
    Microsoft price target raised to $280 from $270 at BMO Capital
    04/09/21 BTIG
    Okta upgraded to Buy from Neutral at BTIG
    NUAN Nuance
    $45.59 /

    +0.38 (+0.84%)

    MSFT Microsoft
    $255.73 /

    +2.37 (+0.94%)

    NUAN Nuance
    $45.59 /

    +0.38 (+0.84%)

    MSFT Microsoft
    $255.73 /

    +2.37 (+0.94%)

    NUAN Nuance
    $45.59 /

    +0.38 (+0.84%)

    MSFT Microsoft
    $255.73 /

    +2.37 (+0.94%)

    NUAN Nuance
    $45.59 /

    +0.38 (+0.84%)

    MSFT Microsoft
    $255.73 /

    +2.37 (+0.94%)

    Options
    Five new option listings on April 12th » 08:30
    04/12/21
    04/12
    08:30
    04/12/21
    08:30
    ACVA

    ACV Auctions

    $31.29 /

    -0.31 (-0.98%)

    , DSEY

    Diversey

    $14.79 /

    -0.12 (-0.80%)

    , RICE

    Rice Acquisition

    $17.25 /

    +1.94 (+12.67%)

    , TDUP

    thredUP

    $18.44 /

    +0.07 (+0.38%)

    , ULCC

    Frontier Group

    $21.35 /

    +0.08 (+0.38%)

    New option listings for…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    RICE Rice Acquisition
    $17.25 /

    +1.94 (+12.67%)

    ACVA ACV Auctions
    $31.29 /

    -0.31 (-0.98%)

    03/29/21 Northcoast
    ACV Auctions initiated with a Neutral at Northcoast
    DSEY Diversey
    $14.79 /

    -0.12 (-0.80%)

    RICE Rice Acquisition
    $17.25 /

    +1.94 (+12.67%)

    TDUP thredUP
    $18.44 /

    +0.07 (+0.38%)

    ULCC Frontier Group
    $21.35 /

    +0.08 (+0.38%)

    • 01
      Apr
    • 26
      Mar
    • 25
      Mar
    • 24
      Mar
    ACVA ACV Auctions
    $31.29 /

    -0.31 (-0.98%)

    DSEY Diversey
    $14.79 /

    -0.12 (-0.80%)

    RICE Rice Acquisition
    $17.25 /

    +1.94 (+12.67%)

    TDUP thredUP
    $18.44 /

    +0.07 (+0.38%)

    ULCC Frontier Group
    $21.35 /

    +0.08 (+0.38%)

    Conference/Events
    Oncolytics to hold a Key Opinion Leader conference call » 08:28
    04/12/21
    04/12
    08:28
    04/12/21
    08:28
    ONCY

    Oncolytics

    $3.99 /

    -0.61 (-13.26%)

    Management holds a Key…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    ONCY Oncolytics
    $3.99 /

    -0.61 (-13.26%)

    ONCY Oncolytics
    $3.99 /

    -0.61 (-13.26%)

    02/17/21 H.C. Wainwright
    Oncolytics initiated with a Buy at H.C. Wainwright
    05/11/20 RBC Capital
    Oncolytics price target lowered to C$6 from C$9 at RBC Capital
    ONCY Oncolytics
    $3.99 /

    -0.61 (-13.26%)

    Periodicals
    Study shows Covid variant may evade protection from Pfizer vaccine, Reuters says » 08:27
    04/12/21
    04/12
    08:27
    04/12/21
    08:27
    PFE

    Pfizer

    $36.60 /

    +0.64 (+1.78%)

    , BNTX

    BioNTech

    $122.15 /

    +7.68 (+6.71%)

    The coronavirus variant…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    PFE Pfizer
    $36.60 /

    +0.64 (+1.78%)

    BNTX BioNTech
    $122.15 /

    +7.68 (+6.71%)

    PFE Pfizer
    $36.60 /

    +0.64 (+1.78%)

    04/09/21
    Pfizer to host conference call
    04/06/21 RBC Capital
    Pfizer transferred with a Sector Perform at RBC Capital
    03/17/21 Mizuho
    AbbVie's FDA request show Xeljanz concerns may bleed to Rinvoq, says Mizuho
    02/23/21 B. Riley Securities
    B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance
    BNTX BioNTech
    $122.15 /

    +7.68 (+6.71%)

    02/23/21 B. Riley Securities
    B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance
    02/01/21 SVB Leerink
    Moderna price target raised to $80 from $69 at SVB Leerink
    01/29/21 Piper Sandler
    Moderna, Pfizer keep Covid vaccine competitive advantage, says Piper Sandler
    01/14/21 Morgan Stanley
    80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
    PFE Pfizer
    $36.60 /

    +0.64 (+1.78%)

    • 23
      Jul
    PFE Pfizer
    $36.60 /

    +0.64 (+1.78%)

    BNTX BioNTech
    $122.15 /

    +7.68 (+6.71%)

    PFE Pfizer
    $36.60 /

    +0.64 (+1.78%)

    BNTX BioNTech
    $122.15 /

    +7.68 (+6.71%)

    PFE Pfizer
    $36.60 /

    +0.64 (+1.78%)

    BNTX BioNTech
    $122.15 /

    +7.68 (+6.71%)

    Hot Stocks
    Kronos Advanced Technologies acquires 600M Dogecoin Cash » 08:25
    04/12/21
    04/12
    08:25
    04/12/21
    08:25
    KNOS

    Kronos Advanced Technologies

    /

    +

    KRONOS ADVANCED…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    Technical Analysis
    DJ Transportation Average: Pivot points » 08:25
    04/12/21
    04/12
    08:25
    04/12/21
    08:25
    $DJT

    DJ Transportation Average

    /

    +

    The following are the…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    $DJT DJ Transportation Average
    /

    +

    Technical Analysis
    DJ Utility Average: Pivot points » 08:25
    04/12/21
    04/12
    08:25
    04/12/21
    08:25
    $DJU

    DJ Utility Average

    /

    +

    The following are the…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    $DJU DJ Utility Average
    /

    +

    Conference/Events
    Incyte to hold a conference call » 08:25
    04/12/21
    04/12
    08:25
    04/12/21
    08:25
    INCY

    Incyte

    $79.97 /

    -0.91 (-1.13%)

    Management discusses…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    INCY Incyte
    $79.97 /

    -0.91 (-1.13%)

    INCY Incyte
    $79.97 /

    -0.91 (-1.13%)

    02/10/21 SVB Leerink
    Incyte downgraded to Market Perform from Outperform at SVB Leerink
    01/07/21 Truist
    Incyte initiated with a Buy at Truist
    01/07/21 Truist
    Incyte initiated with a Buy at Truist
    01/04/21 Guggenheim
    Incyte upgraded to Buy from Neutral at Guggenheim
    INCY Incyte
    $79.97 /

    -0.91 (-1.13%)

    INCY Incyte
    $79.97 /

    -0.91 (-1.13%)

    INCY Incyte
    $79.97 /

    -0.91 (-1.13%)

    INCY Incyte
    $79.97 /

    -0.91 (-1.13%)

    Conference/Events
    Jefferies banking analyst to hold analyst/industry conference call » 08:25
    04/12/21
    04/12
    08:25
    04/12/21
    08:25
    BBVA

    BBVA

    $5.30 /

    -0.125 (-2.30%)

    Banking/Financial Analyst…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    BBVA BBVA
    $5.30 /

    -0.125 (-2.30%)

    BBVA BBVA
    $5.30 /

    -0.125 (-2.30%)

    04/09/21 Morgan Stanley
    BBVA price target raised to EUR 4.90 from EUR 4.70 at Morgan Stanley
    03/04/21 Barclays
    BBVA downgraded to Equal Weight from Overweight at Barclays
    02/26/21 UBS
    BBVA price target raised to EUR 4.50 from EUR 4.30 at UBS
    02/25/21 Jefferies
    BBVA upgraded to Buy from Hold at Jefferies
    BBVA BBVA
    $5.30 /

    -0.125 (-2.30%)

    BBVA BBVA
    $5.30 /

    -0.125 (-2.30%)

    BBVA BBVA
    $5.30 /

    -0.125 (-2.30%)

    Conference/Events
    Morgan Stanely economist/strategist hold analyst/industry conference call » 08:25
    04/12/21
    04/12
    08:25
    04/12/21
    08:25

    US Public Policy &…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    Technical Analysis
    Dow Jones Industrial Average: Pivot points » 08:24
    04/12/21
    04/12
    08:24
    04/12/21
    08:24
    DJX

    Dow Jones Industrial Average

    /

    +

    The following are the…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    DJX Dow Jones Industrial Average
    /

    +

    Technical Analysis
    iShares Transportation Average: Pivot points » 08:24
    04/12/21
    04/12
    08:24
    04/12/21
    08:24
    IYT

    iShares Transportation Average

    $262.17 /

    +2.04 (+0.78%)

    The following are the…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    IYT iShares Transportation Average
    $262.17 /

    +2.04 (+0.78%)

    Technical Analysis
    Technology Select Sector SPDR: Pivot points » 08:24
    04/12/21
    04/12
    08:24
    04/12/21
    08:24
    XLK

    Technology Select Sector SPDR

    $141.74 /

    +1.3 (+0.93%)

    The following are the…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    XLK Technology Select Sector SPDR
    $141.74 /

    +1.3 (+0.93%)

    06/10/20 Jefferies
    Jefferies downgrades Tech sector to Market Weight from Overweight
    XLK Technology Select Sector SPDR
    $141.74 /

    +1.3 (+0.93%)

    Technical Analysis
    Energy Select Sector SPDR: Pivot points » 08:24
    04/12/21
    04/12
    08:24
    04/12/21
    08:24
    XLE

    Energy Select Sector SPDR

    $48.24 /

    -0.27 (-0.56%)

    The following are the…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    XLE Energy Select Sector SPDR
    $48.24 /

    -0.27 (-0.56%)

    XLE Energy Select Sector SPDR
    $48.24 /

    -0.27 (-0.56%)

    03/12/21
    On The Fly: Weekly technical notes for S&P 500
    07/06/20 Goldman Sachs
    Rattler Midstream downgraded to Neutral from Buy at Goldman Sachs
    XLE Energy Select Sector SPDR
    $48.24 /

    -0.27 (-0.56%)

    XLE Energy Select Sector SPDR
    $48.24 /

    -0.27 (-0.56%)

    Technical Analysis
    Consumer Discretionary Sector SPDR: Pivot points » 08:23
    04/12/21
    04/12
    08:23
    04/12/21
    08:23
    XLY

    Consumer Discretionary Sector SPDR

    $175.98 /

    +1.71 (+0.98%)

    The following are the…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    XLY Consumer Discretionary Sector SPDR
    $175.98 /

    +1.71 (+0.98%)

    03/12/21
    On The Fly: Weekly technical notes for S&P 500
    XLY Consumer Discretionary Sector SPDR
    $175.98 /

    +1.71 (+0.98%)

    XLY Consumer Discretionary Sector SPDR
    $175.98 /

    +1.71 (+0.98%)

    Technical Analysis
    S&P Select Materials SPDR: Pivot points » 08:23
    04/12/21
    04/12
    08:23
    04/12/21
    08:23
    XLB

    S&P Select Materials SPDR

    $80.03 /

    +0.66 (+0.83%)

    The following are the…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    XLB S&P Select Materials SPDR
    $80.03 /

    +0.66 (+0.83%)

    03/12/21
    On The Fly: Weekly technical notes for S&P 500
    06/10/20 Jefferies
    Jefferies downgrades Tech sector to Market Weight from Overweight
    XLB S&P Select Materials SPDR
    $80.03 /

    +0.66 (+0.83%)

    XLB S&P Select Materials SPDR
    $80.03 /

    +0.66 (+0.83%)

    Recommendations
    Chicken Soup for the Soul price target raised to $40 from $30 at Northland » 08:23
    04/12/21
    04/12
    08:23
    04/12/21
    08:23
    CSSE

    Chicken Soup for the Soul

    $32.50 /

    +4.54 (+16.24%)

    Northland analyst Mike…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    CSSE Chicken Soup for the Soul
    $32.50 /

    +4.54 (+16.24%)

    CSSE Chicken Soup for the Soul
    $32.50 /

    +4.54 (+16.24%)

    04/09/21 Alliance Global Partners
    Alliance Global raises Chicken Soup for the Soul price target to $48 after deal
    04/01/21 DA Davidson
    Chicken Soup for the Soul price target raised to $34 from $28 at DA Davidson
    04/01/21 Craig-Hallum
    Chicken Soup for the Soul price target raised to $35 from $30 at Craig-Hallum
    04/01/21 Northland
    Chicken Soup for the Soul price target raised to $30 from $18 at Northland

    Get Full Fly Access

    Breaking market intelligence sent straight to you
    Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
    Up-to-date information on important industry events
    Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
    News focused on the companies in your portfolio
    Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.